These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 1672622)

  • 1. Secretion of lysosomal enzymes by drug-sensitive and multiple drug-resistant cells.
    Warren L; Jardillier JC; Ordentlich P
    Cancer Res; 1991 Apr; 51(8):1996-2001. PubMed ID: 1672622
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Energy-dependent reduced drug binding as a mechanism of Vinca alkaloid resistance in human leukemic lymphoblasts.
    Beck WT; Cirtain MC; Lefko JL
    Mol Pharmacol; 1983 Nov; 24(3):485-92. PubMed ID: 6579344
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytogenetic and molecular characterization of tumors in nude mice derived from a multidrug-resistant human leukemia cell line.
    Hill AB; Beck WT; Trent JM
    Cancer Res; 1988 Jan; 48(2):393-8. PubMed ID: 2891436
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Continued expression of vinca alkaloid resistance by CCRF-CEM cells after treatment with tunicamycin or pronase.
    Beck WT; Cirtain MC
    Cancer Res; 1982 Jan; 42(1):184-9. PubMed ID: 7198507
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacological, molecular, and cytogenetic analysis of "atypical" multidrug-resistant human leukemic cells.
    Beck WT; Cirtain MC; Danks MK; Felsted RL; Safa AR; Wolverton JS; Suttle DP; Trent JM
    Cancer Res; 1987 Oct; 47(20):5455-60. PubMed ID: 2888532
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Study of sodium orthovanadate as a reverser of multidrug resistance on lymphoblastic leukemic CEM/VLB100 cells.
    Colin M; Madoulet C; Baccard N; Arsac F; Jardillier JC
    Anticancer Res; 1994; 14(6A):2383-7. PubMed ID: 7825977
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of duration of exposure to verapamil on vincristine activity against multidrug-resistant human leukemic cell lines.
    Cass CE; Janowska-Wieczorek A; Lynch MA; Sheinin H; Hindenburg AA; Beck WT
    Cancer Res; 1989 Nov; 49(21):5798-804. PubMed ID: 2790792
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reversal of Vinca alkaloid resistance but not multiple drug resistance in human leukemic cells by verapamil.
    Beck WT; Cirtain MC; Look AT; Ashmun RA
    Cancer Res; 1986 Feb; 46(2):778-84. PubMed ID: 3455678
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alterations of vinblastine influx in multidrug-resistant lymphoblastic leukaemic CEM cells.
    Colin M; Madoulet C; Warren L; Jardillier JC
    Anticancer Res; 1996; 16(1):407-12. PubMed ID: 8615645
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased accumulation of drugs in multidrug-resistant cells induced by liposomes.
    Warren L; Jardillier JC; Malarska A; Akeli MG
    Cancer Res; 1992 Jun; 52(11):3241-5. PubMed ID: 1591733
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A flow cell assay for evaluation of whole cell drug efflux kinetics: analysis of paclitaxel efflux in CCRF-CEM leukemia cells overexpressing P-glycoprotein.
    Lin JT; Sharma R; Grady JJ; Awasthi S
    Drug Metab Dispos; 2001 Feb; 29(2):103-10. PubMed ID: 11159798
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Selective modulation of P-glycoprotein-mediated drug resistance.
    Bebawy M; Morris MB; Roufogalis BD
    Br J Cancer; 2001 Dec; 85(12):1998-2003. PubMed ID: 11747345
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Resistance to tetracycline, a hydrophilic antibiotic, is mediated by P-glycoprotein in human multidrug-resistant cells.
    Kavallaris M; Madafiglio J; Norris MD; Haber M
    Biochem Biophys Res Commun; 1993 Jan; 190(1):79-85. PubMed ID: 8093660
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Atypical multidrug resistance in a therapy-induced drug-resistant human leukemia cell line (LALW-2): resistance to Vinca alkaloids independent of P-glycoprotein.
    Haber M; Norris MD; Kavallaris M; Bell DR; Davey RA; White L; Stewart BW
    Cancer Res; 1989 Oct; 49(19):5281-7. PubMed ID: 2569932
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ultrastructural changes related to multidrug resistance in CEM cells: role of cytoplasmic vesicles in drug exclusion.
    Bobichon H; Colin M; Depierreux C; Liautaud-Roger F; Jardillier JC
    J Exp Ther Oncol; 1996 Jan; 1(1):49-61. PubMed ID: 9414388
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reversal of P-glycoprotein-mediated multidrug resistance by cholesterol derived from low density lipoprotein in a vinblastine-resistant human lymphoblastic leukemia cell line.
    Shu Y; Liu H
    Biochem Cell Biol; 2007 Oct; 85(5):638-46. PubMed ID: 17901905
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combined use of cyclosporin A and verapamil in modulating multidrug resistance in human leukemia cell lines.
    Hu XF; Martin TJ; Bell DR; de Luise M; Zalcberg JR
    Cancer Res; 1990 May; 50(10):2953-7. PubMed ID: 2334897
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Scanning electron microscopy of multidrug resistant cells in haematological and mammary malignancies.
    Galimberti S; Bianchi F; Bernardini N; Mattii L; Dolfi A; Lupetti M; Petrini M
    Cell Mol Biol (Noisy-le-grand); 1993 Jul; 39(5):543-51. PubMed ID: 8104068
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of monoclonal antibodies recognizing a Mr 180,000 P-glycoprotein: differential expression of the Mr 180,000 and Mr 170,000 P-glycoproteins in multidrug-resistant human tumor cells.
    Meyers MB; Rittmann-Grauer L; O'Brien JP; Safa AR
    Cancer Res; 1989 Jun; 49(12):3209-14. PubMed ID: 2566379
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cross-resistance of human multidrug-resistant cells to mitomycin C.
    Yusa K; Sato W; Yamazaki A; Tsukahara S; Tsuruo T
    Anticancer Res; 1991; 11(3):1301-4. PubMed ID: 1909515
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.